Ron Dabby

Dr. Ron Dabby


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2009 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
RDRon Dabby
Ron Dabby
MSMenachem Sadeh
Menachem Sadeh
YLYair Lampl
Yair Lampl
RGRonit Gilad
Ronit Gilad
NWNathan Watemberg
Nathan Watemberg

1 February 2011 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
RDRon Dabby
Ron Dabby
MSMenachem Sadeh
Menachem Sadeh
RGRonit Gilad
Ronit Gilad
YLYair Lampl
Yair Lampl
SCSarit Cohen
Sarit Cohen
ELEsther Leshinsky-Silver
Esther Leshinsky-Silver

11 June 2007 in Journal of the Peripheral Nervous System
Verified
Journal Article
Closed access
PDF file
RDRon Dabby
Ron Dabby
HVHananya Vaknine
Hananya Vaknine
RGRonit Gilad
Ronit Gilad
RDRuth Djaldetti
Ruth Djaldetti
MSMenachem Sadeh
Menachem Sadeh

8 October 2011 in Current Neurology and Neuroscience Reports
Verified
Journal Article
Closed access
PDF file
RDRon Dabby
Ron Dabby

17 November 2006 in Journal of the Peripheral Nervous System
Verified
Journal Article
Closed access
PDF file
RDRon Dabby
Ron Dabby
RDRuth Djaldetti
Ruth Djaldetti
RGRonit Gilad
Ronit Gilad
OHOscar Herman
Oscar Herman
JFJacob Frand
Jacob Frand
NWNathan Watemberg
Nathan Watemberg

1 November 2017 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
RDRon Dabby
Ron Dabby
MSMenachem Sadeh
Menachem Sadeh
IGIlan Goldberg
Ilan Goldberg
VFVitaly Finkelshtein
Vitaly Finkelshtein
Peripheral neuropathic pain (PNP) is caused by neuronal damage to the peripheral nervous system and usually affects the distal extremities. This open-label study examined the effect of short-term peripheral nerve stimulation (PNS) on individuals with PNP due to polyneuropathy. A total of 12 patients (mean age, 63.0 ± 10.0 years, 41.7% male) with daily bilateral PNP for at least 6 months (mean duration, 7.4 ± 7.8 years) received a total of six direct electrical stimulation therapies to the posterior tibial nerve at 3–4-day intervals. Eight patients completed the study and were included in the efficacy analysis. The average pain at baseline was 36.6 ± 3.80 estimated by the Short-Form McGill Pain Questionnaire. After the last stimulation, pain was significantly reduced by 85.5% to 4.88 ± 3.1 (p = 0.008). Six patients (75%) had over 50% decrease in pain after the first stimulation therapy and 99.2% after the final stimulation therapy. The patients also reported statistically significant decreases in pain level (measured by visual analog scale), ranging from 54.85% to 87.50% after each of the stimulations as compared to the pain experienced prior to the stimulations. The procedure was safe without any serious adverse events. PNS has demonstrated excellent efficacy and improvement of PNP symptoms. Further studies in larger patient populations are warranted.